These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 30216500)
1. The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer. Chen X; Liu M; Meng F; Sun B; Jin X; Jia C J Cell Biochem; 2019 Jan; 120(1):243-252. PubMed ID: 30216500 [TBL] [Abstract][Full Text] [Related]
2. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306 [TBL] [Abstract][Full Text] [Related]
3. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis. Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HIF1A-AS2 facilitates cell survival and migration by sponging miR-33b-5p to modulate SIRT6 expression in osteosarcoma. Lin H; Zhao Z; Hao Y; He J; He J Biochem Cell Biol; 2020 Apr; 98(2):284-292. PubMed ID: 31626739 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA HIF1A-AS2 promotes carcinogenesis by enhancing Gli1-mediated HIF1α expression in clear cell renal cell carcinoma. Li X; Wu Y; Xiao Z; Liu Y; Wang C; Zhou L; Yang X Pathol Res Pract; 2024 Jan; 253():154984. PubMed ID: 38064865 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer. Yang K; Zhang W; Zhong L; Xiao Y; Sahoo S; Fassan M; Zeng K; Magee P; Garofalo M; Shi L Cell Death Differ; 2023 Jun; 30(6):1533-1549. PubMed ID: 37041291 [TBL] [Abstract][Full Text] [Related]
7. lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia. Li L; Wang M; Mei Z; Cao W; Yang Y; Wang Y; Wen A Biomed Pharmacother; 2017 Dec; 96():165-172. PubMed ID: 28985553 [TBL] [Abstract][Full Text] [Related]
8. LncRNA HIF1A-AS2 mediates imatinib resistance by regulating autophagy in gastrointestinal stromal tumor cells. Yan J; Chen X; Lin J; Sun X; Chen W Neoplasma; 2023 Aug; 70(4):526-533. PubMed ID: 37789783 [TBL] [Abstract][Full Text] [Related]
9. LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling. Chen J; Li Y; Li Z; Cao L J Biochem Mol Toxicol; 2020 Apr; 34(4):e22452. PubMed ID: 32052927 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-Induced Long Noncoding RNA HIF1A-AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer. Liao TT; Chen YH; Li ZY; Hsiao AC; Huang YL; Hao RX; Tai SK; Chu PY; Shih JW; Kung HJ; Yang MH Cancer Immunol Res; 2024 Oct; 12(10):1468-1484. PubMed ID: 38920249 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of HIF1A-AS2 suppresses TRIM44 to protect cardiomyocytes against hypoxia-induced injury. Luo F; Wu Y; Zhu L; Zhang J; Liu Y; Jia W Cell Biol Int; 2020 Jul; 44(7):1523-1534. PubMed ID: 32222118 [TBL] [Abstract][Full Text] [Related]
12. HIF1A-AS2 predicts poor prognosis and regulates cell migration and invasion in triple-negative breast cancer. Wang Y; Zhang G; Han J J Cell Biochem; 2019 Jun; 120(6):10513-10518. PubMed ID: 30635931 [TBL] [Abstract][Full Text] [Related]
13. LncRNA HIF1A-AS2 modulated by HPV16 E6 regulates apoptosis of cervical cancer cells via P53/caspase9/caspase3 axis. Guan HM; Li WQ; Liu J; Zhou JY Cell Signal; 2022 Sep; 97():110390. PubMed ID: 35728704 [TBL] [Abstract][Full Text] [Related]
14. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion. Xue M; Li X; Li Z; Chen W Tumour Biol; 2014 Jul; 35(7):6901-12. PubMed ID: 24737584 [TBL] [Abstract][Full Text] [Related]
15. HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis. Zhong X; Wang Y; He X; He X; Hu Z; Huang H; Chen J; Chen K; Wei P; Zhao S; Wang Y; Zhang H; Feng B; Li D Cell Death Dis; 2024 Sep; 15(9):645. PubMed ID: 39227375 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y FEBS J; 2014 Apr; 281(7):1750-8. PubMed ID: 24495014 [TBL] [Abstract][Full Text] [Related]
17. LncRNA HIF1A-AS2: a potential biomarker for early diagnosis of acute myocardial infarction and predictor of left ventricular dysfunction. Tayae E; Amr E; Zaki A; Elkaffash D BMC Cardiovasc Disord; 2023 Mar; 23(1):135. PubMed ID: 36918770 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA HIF1A-AS2 facilitates adipose-derived stem cells (ASCs) osteogenic differentiation through miR-665/IL6 axis via PI3K/Akt signaling pathway. Wu R; Ruan J; Sun Y; Liu M; Sha Z; Fan C; Wu Q Stem Cell Res Ther; 2018 Dec; 9(1):348. PubMed ID: 30545407 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of long noncoding RNA HIF1A-AS2 confers protection against atherosclerosis Li P; Xing J; Zhang J; Jiang J; Liu X; Zhao D; Zhang Y J Adv Res; 2020 Nov; 26():123-135. PubMed ID: 33133688 [TBL] [Abstract][Full Text] [Related]
20. [Silencing long non-coding RNA HIF1A-AS2 inhibits proliferation, invasion and migration of cervical cancer cells Deng R; Zhang F; Lei F; Liu W; Liu S; Wang W Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1615-1621. PubMed ID: 33243752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]